Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9099938rdf:typepubmed:Citationlld:pubmed
pubmed-article:9099938lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:9099938lifeskim:mentionsumls-concept:C1334292lld:lifeskim
pubmed-article:9099938lifeskim:mentionsumls-concept:C0014609lld:lifeskim
pubmed-article:9099938lifeskim:mentionsumls-concept:C0022663lld:lifeskim
pubmed-article:9099938lifeskim:mentionsumls-concept:C0017661lld:lifeskim
pubmed-article:9099938lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:9099938lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:9099938lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:9099938pubmed:issue3lld:pubmed
pubmed-article:9099938pubmed:dateCreated1997-5-5lld:pubmed
pubmed-article:9099938pubmed:abstractTextJak3 is a member of the Janus kinase family which plays an important role in cytokine signal transduction. Jak3 associates the gamma(c) chain of receptors for IL-2, IL-4, IL-7, IL-9 and IL-15, and is essential for the signal transduction of these cytokines. We have isolated Jak3 kinase from renal mesangial cells and demonstrated the constitutive expression of Jak3 in glomeruli in vivo. To investigate the physiological and pathological role of Jak3 in glomeruli, we prepared anti-Jak3 antibody and analysed the localization of Jak3 in glomeruli of renal biopsy samples from various nephritis patients and normal subjects. Among 61 nephritis patients and four normal subjects investigated in the present study, Jak3 was selectively localized to glomerular epithelia of IgA-N patients (14/34 cases) and focal glomerulosclerosis patients (1/5 cases), but not detected in minimal changes (n = 6), membranous glomerulonephropathy (n = 7), crescentic glomerulonephritis (n = 4), lupus nephritis patients (n = 5), and normal subjects (n = 4). The intense immunoreactivity for Jak3 is significantly associated with the decrease in creatinine clearance (81.5 +/- 10.4 ml/min versus 104.3 +/- 29.6 ml/min; P < 0.05, Student's t-test) and the increase in level of serum creatinine (1.13 +/- 0.33 mg/dl versus 0.75 +/- 0.23 mg/dl; P < 0.01, Student's t-test) in IgA-N patients. Furthermore, gamma(c) chain was concomitantly expressed with Jak3 in glomerular epithelia in vivo and in vitro, suggesting that signal transduction via gamma(c)-Jak3 cascade may be involved in the pathogenesis of glomerular injury of IgA-N. Taken together with the recent findings that IL-4-secreting T lymphocytes in affected glomeruli injure glomerular epithelium, the responsiveness of glomerular epithelium for IL-4 may be pathologically enhanced in IgA-N.lld:pubmed
pubmed-article:9099938pubmed:languageenglld:pubmed
pubmed-article:9099938pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9099938pubmed:citationSubsetIMlld:pubmed
pubmed-article:9099938pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9099938pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9099938pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9099938pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9099938pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9099938pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9099938pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9099938pubmed:statusMEDLINElld:pubmed
pubmed-article:9099938pubmed:monthJunlld:pubmed
pubmed-article:9099938pubmed:issn0009-9104lld:pubmed
pubmed-article:9099938pubmed:authorpubmed-author:TakahashiTTlld:pubmed
pubmed-article:9099938pubmed:authorpubmed-author:AbeAAlld:pubmed
pubmed-article:9099938pubmed:authorpubmed-author:YamabeHHlld:pubmed
pubmed-article:9099938pubmed:authorpubmed-author:SakaiOOlld:pubmed
pubmed-article:9099938pubmed:authorpubmed-author:NatoriYYlld:pubmed
pubmed-article:9099938pubmed:authorpubmed-author:UtsunomiyaYYlld:pubmed
pubmed-article:9099938pubmed:authorpubmed-author:MiyakeKKlld:pubmed
pubmed-article:9099938pubmed:authorpubmed-author:MaruyamaNNlld:pubmed
pubmed-article:9099938pubmed:authorpubmed-author:YahagiYYlld:pubmed
pubmed-article:9099938pubmed:authorpubmed-author:MitaraiTTlld:pubmed
pubmed-article:9099938pubmed:authorpubmed-author:ShirasawaTTlld:pubmed
pubmed-article:9099938pubmed:authorpubmed-author:MatsumuraOOlld:pubmed
pubmed-article:9099938pubmed:issnTypePrintlld:pubmed
pubmed-article:9099938pubmed:volume104lld:pubmed
pubmed-article:9099938pubmed:ownerNLMlld:pubmed
pubmed-article:9099938pubmed:authorsCompleteYlld:pubmed
pubmed-article:9099938pubmed:pagination517-24lld:pubmed
pubmed-article:9099938pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:9099938pubmed:meshHeadingpubmed-meshheading:9099938-...lld:pubmed
pubmed-article:9099938pubmed:meshHeadingpubmed-meshheading:9099938-...lld:pubmed
pubmed-article:9099938pubmed:meshHeadingpubmed-meshheading:9099938-...lld:pubmed
pubmed-article:9099938pubmed:meshHeadingpubmed-meshheading:9099938-...lld:pubmed
pubmed-article:9099938pubmed:meshHeadingpubmed-meshheading:9099938-...lld:pubmed
pubmed-article:9099938pubmed:meshHeadingpubmed-meshheading:9099938-...lld:pubmed
pubmed-article:9099938pubmed:meshHeadingpubmed-meshheading:9099938-...lld:pubmed
pubmed-article:9099938pubmed:meshHeadingpubmed-meshheading:9099938-...lld:pubmed
pubmed-article:9099938pubmed:meshHeadingpubmed-meshheading:9099938-...lld:pubmed
pubmed-article:9099938pubmed:meshHeadingpubmed-meshheading:9099938-...lld:pubmed
pubmed-article:9099938pubmed:meshHeadingpubmed-meshheading:9099938-...lld:pubmed
pubmed-article:9099938pubmed:meshHeadingpubmed-meshheading:9099938-...lld:pubmed
pubmed-article:9099938pubmed:meshHeadingpubmed-meshheading:9099938-...lld:pubmed
pubmed-article:9099938pubmed:meshHeadingpubmed-meshheading:9099938-...lld:pubmed
pubmed-article:9099938pubmed:meshHeadingpubmed-meshheading:9099938-...lld:pubmed
pubmed-article:9099938pubmed:meshHeadingpubmed-meshheading:9099938-...lld:pubmed
pubmed-article:9099938pubmed:meshHeadingpubmed-meshheading:9099938-...lld:pubmed
pubmed-article:9099938pubmed:meshHeadingpubmed-meshheading:9099938-...lld:pubmed
pubmed-article:9099938pubmed:meshHeadingpubmed-meshheading:9099938-...lld:pubmed
pubmed-article:9099938pubmed:meshHeadingpubmed-meshheading:9099938-...lld:pubmed
pubmed-article:9099938pubmed:meshHeadingpubmed-meshheading:9099938-...lld:pubmed
pubmed-article:9099938pubmed:meshHeadingpubmed-meshheading:9099938-...lld:pubmed
pubmed-article:9099938pubmed:meshHeadingpubmed-meshheading:9099938-...lld:pubmed
pubmed-article:9099938pubmed:meshHeadingpubmed-meshheading:9099938-...lld:pubmed
pubmed-article:9099938pubmed:meshHeadingpubmed-meshheading:9099938-...lld:pubmed
pubmed-article:9099938pubmed:meshHeadingpubmed-meshheading:9099938-...lld:pubmed
pubmed-article:9099938pubmed:meshHeadingpubmed-meshheading:9099938-...lld:pubmed
pubmed-article:9099938pubmed:meshHeadingpubmed-meshheading:9099938-...lld:pubmed
pubmed-article:9099938pubmed:year1996lld:pubmed
pubmed-article:9099938pubmed:articleTitleJak3 expression in glomerular epithelia of IgA nephropathy (IgA-N) patients.lld:pubmed
pubmed-article:9099938pubmed:affiliationDepartment of Molecular Pathology, Tokyo Metropolitan Institute of Gerontology, Itabashi-ku, Japan.lld:pubmed
pubmed-article:9099938pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9099938pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed